Results 271 to 280 of about 38,575 (293)

Proprotein convertase 1

1998
Dietmar Schomburg, Dörte Stephan
openaire   +2 more sources

Proprotein Convertase Subtilisin/Kexin Type 9 Promotes Gastric Cancer Metastasis and Suppresses Apoptosis by Facilitating MAPK Signaling Pathway Through HSP70 Up-Regulation

Frontiers in Oncology, 2020
Shuyu Li, Yong Fang
exaly  

Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Independently Associated with Insulin Resistance, Triglycerides, Lipoprotein(a) Levels but not Low-Density Lipoprotein Cholesterol Levels in a General Population

Journal of Atherosclerosis and Thrombosis, 2021
Hisashi Adachi, Ako Fukami, Annie-pier Trottier   +2 more
exaly  

Defective processing of neuropeptide precursors in Caenorhabditis elegans lacking proprotein convertase 2 (KPC-2/EGL-3): mutant analysis by mass spectrometry

Journal of Neurochemistry, 2006
Geert Baggerman, Liliane Schoofs, Xin Chen   +2 more
exaly  

Implication of the proprotein convertase NARC-1/PCSK9 in the development of the nervous system

Journal of Neurochemistry, 2006
Annik Prat, Nabil G Seidah, Yong He
exaly  

Proprotein Convertase Furin and Proprotein Convertase PC5/6

2013
openaire   +1 more source

Effect of proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibodies on new‐onset diabetes mellitus and glucose metabolism: A systematic review and meta‐analysis

Diabetes, obesity and metabolism, 2018
Yexuan Cao, Huihui Liu, Q. Dong, Sha Li, Jian‐Jun Li   +4 more
semanticscholar   +1 more source

On the cutting edge of proprotein convertase pharmacology: from molecular concepts to clinical applications

Biomolecular Concepts, 2011
Robert Day, Frédéric Couture
exaly  

The Role of a Proprotein Convertase Inhibitor in Reactivation of Tumor-Associated Macrophages and Inhibition of Glioma Growth

Molecular Therapy - Oncolytics, 2020
Mélanie Rose, Marie Duhamel, Soulaimane Aboulouard   +2 more
exaly  

Targeting proprotein convertases in furin‐rich lung cancer cells results in decreased in vitro and in vivo growth

Molecular Carcinogenesis, 2017
Andres J Klein-szanto
exaly